drugset / Trial / NCT02253797
Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Study to evaluate the pharmacokinetics of Tipranavir and its metabolites including excretion and mass balance of parent compound and radioactivity at steady-state; to isolate, identify and quantify major metabolites of tipranavir in plasma, urine and feces
Timeline
- Start
- 2003-07
- Primary completion
- 2003-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tipranavir | Small molecule | 500 mg | Oral |
| Background | Ritonavir | Other / unclassified | 200 mg | Oral |
Indications
No indication recorded.